4//SEC Filing
BOYNTON ALTON L 4
Accession 0001104659-20-080807
CIK 0001072379other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 9:55 PM ET
Size
5.8 KB
Accession
0001104659-20-080807
Insider Transaction Report
Form 4
BOYNTON ALTON L
DirectorChief Executive Officer
Transactions
- Award
Options to purchase Common Stock, par value $0.001
2020-07-02+15,697,693→ 15,697,693 totalExercise: $0.25From: 2020-12-01Exp: 2030-12-01→ Common Stock, par value $0.001 (15,697,693 underlying)
Footnotes (1)
- [F1]These options were awarded in part for service during the last 2 years. However, the documents to implement and issue (grant) them have not been executed until now. The $0.25 exercise price was determined with reference to the pricing for unrelated investors at the time of approval, which was the trailing 10-day average closing market price of the Company's stock, which was about $0.22. These options are subject to certain vesting requirements. They are also suspended and will not become exercisable until December 1, 2020.
Documents
Issuer
NORTHWEST BIOTHERAPEUTICS INC
CIK 0001072379
Entity typeother
Related Parties
1- filerCIK 0001253935
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 9:55 PM ET
- Size
- 5.8 KB